Samtidig indgivelse af Sonata og CYP3A4 fremmere 15 som f. eks. rifampicin, carbamazepin og phenobarbiton kan resultere i en reduktion af zaleplons virkning.
Co-administration of Sonata together with inducers of CYP3A4 such as rifampicin, carbamazepine and phenobarbitone, may result in a reduction of zaleplon’ s efficacy.